Mitsui Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

MitsuiDer Gewinn des Unternehmens wird voraussichtlich um 3.8% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 0.1% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.4% betragen.

Wichtige Informationen

-3.8%

Wachstumsrate der Gewinne

-1.1%

EPS-Wachstumsrate

Trade Distributors Gewinnwachstum	3.0%
Wachstumsrate der Einnahmen	0.1%
Zukünftige Eigenkapitalrendite	11.4%
Analystenabdeckung	Good
Zuletzt aktualisiert	27 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

May 04

Recent updates

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

May 25

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

May 04

Gewinn- und Umsatzwachstumsprognosen

TSE:8031 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	13,515,522	943,084	623,590	1,012,956	7
3/31/2026	13,305,419	926,801	603,082	1,078,561	9
3/31/2025	13,424,751	926,041	729,928	1,187,124	8
3/31/2024	13,324,942	1,063,684	569,648	864,419	N/A
12/31/2023	13,268,359	1,016,250	854,366	1,129,245	N/A
9/30/2023	13,260,025	1,047,787	943,039	1,203,663	N/A
6/30/2023	13,735,002	1,108,480	896,454	1,133,430	N/A
3/31/2023	14,306,402	1,130,630	819,472	1,047,537	N/A
12/31/2022	14,204,645	1,122,253	828,221	1,047,769	N/A
9/30/2022	13,765,175	1,049,196	606,857	810,110	N/A
6/30/2022	12,820,056	998,458	715,267	908,526	N/A
3/31/2022	11,757,559	914,722	621,371	806,896	N/A
12/31/2021	10,859,096	769,777	448,904	629,269	N/A
9/30/2021	9,721,360	630,064	520,042	699,016	N/A
6/30/2021	8,822,896	464,165	607,883	787,963	N/A
3/31/2021	8,010,235	335,458	557,006	772,696	N/A
12/31/2020	9,030,709	255,374	389,170	641,955	N/A
9/30/2020	8,777,968	267,384	289,611	580,535	N/A
6/30/2020	8,696,383	329,034	254,470	562,537	N/A
3/31/2020	8,484,130	391,513	238,537	526,376	N/A
12/31/2019	7,138,544	399,223	149,575	436,068	N/A
9/30/2019	7,155,418	425,498	284,193	575,690	N/A
6/30/2019	7,034,445	420,837	102,170	403,934	N/A
3/31/2019	6,957,524	414,215	102,951	410,670	N/A
12/31/2018	6,252,108	391,713	233,276	512,138	N/A
9/30/2018	5,711,458	403,042	326,549	553,773	N/A
6/30/2018	5,266,688	426,137	282,735	485,498	N/A
3/31/2018	4,892,149	418,479	379,491	553,645	N/A
12/31/2017	4,841,203	452,637	N/A	586,104	N/A
9/30/2017	4,725,866	422,466	N/A	492,570	N/A
6/30/2017	4,525,658	355,747	N/A	567,464	N/A
3/31/2017	4,363,969	306,136	N/A	404,171	N/A
12/31/2016	4,261,355	12,485	N/A	406,177	N/A
9/30/2016	4,293,998	-92,074	N/A	334,578	N/A
6/30/2016	4,495,976	-119,202	N/A	452,353	N/A
3/31/2016	4,759,694	-83,410	N/A	586,991	N/A
12/31/2015	4,912,066	186,513	N/A	572,788	N/A
9/30/2015	5,155,193	214,471	N/A	591,822	N/A
6/30/2015	5,318,093	275,621	N/A	683,952	N/A
3/31/2015	5,404,930	306,490	N/A	639,967	N/A
12/31/2014	5,574,755	287,616	N/A	552,354	N/A
9/30/2014	5,615,020	369,063	N/A	583,650	N/A
6/30/2014	5,695,151	344,931	N/A	496,615	N/A
3/31/2014	5,731,918	350,093	N/A	449,243	N/A
12/31/2013	5,659,799	359,606	N/A	457,526	N/A
9/30/2013	5,410,687	331,976	N/A	467,519	N/A
6/30/2013	5,139,632	325,144	N/A	404,048	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 8031Für die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-5.7% pro Jahr).

Ertrag vs. Markt: 8031Für die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-5.7% pro Jahr).

Hohe Wachstumserträge: 8031Für die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: 8031Die Einnahmen des Unternehmens (0.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt JP (4.1% pro Jahr).

Hohe Wachstumseinnahmen: 8031Die Einnahmen des Unternehmens (0.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 8031Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.7 %).

Mitsui Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

Price target increased by 7.8% to JP¥7,378

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Price target increased to JP¥4,418

Recent updates

Mitsui & Co., Ltd. to Report Q1, 2025 Results on Aug 01, 2024

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Mitsui (TSE:8031) Takes On Some Risk With Its Use Of Debt

Mitsui & Co., Ltd. Just Beat EPS By 8.6%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.8% to JP¥7,378

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 40,000,000 shares, representing 2.66% for ¥200,000 million.

Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.

Mitsui (TSE:8031) Is Due To Pay A Dividend Of ¥85.00

Mitsui & Co., Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Upcoming dividend of JP¥85.00 per share

Mitsui & Co., Ltd.'s (TSE:8031) Prospects Need A Boost To Lift Shares

Mitsui's (TSE:8031) Dividend Will Be ¥85.00

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Third quarter 2024 earnings: Revenues exceed analyst expectations

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

RGF Staffing B.V. entered into share sale and purchase agreement to acquire additional 30% stake in RGF Staffing Delaware, Inc. from Mitsui & Co., Ltd. (TSE:8031) for approximately 130 million.

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 12,500,000 shares, representing 0.83% for ¥50,000 million.

Second quarter 2024 earnings: EPS misses analyst expectations

BEMAC Corporation and Mitsui & Co., Ltd. entered into a share purchase agreement to acquire 100% of the shares of The Switch Engineering Oy from YASKAWA Electric Corporation.

Mitsui & Co., Ltd. to Report First Half, 2024 Results on Oct 31, 2023

Upcoming dividend of JP¥75.00 per share at 2.6% yield

Mitsui & Co., Ltd. (TSE:8031) completed the acquisition of 49% stake in Solar Park Kassø Aps from European Energy A/S.

Mitsui & Co., Ltd. (TSE:8031) acquired 33.3% stake in Terreva Renewables, LLC from CIM Group, L.P.

CPC Reportedly Set for Dorado Stake

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Dermaceutical Laboratories Limited Liability Company.

Mitsui & Co., Ltd. to Report Q1, 2024 Final Results on Aug 09, 2023

Beacon Rail Metro Finance B.V. signed a share purchase agreement to acquire Mitsui Rail Capital Europe B.V. from Mitsui & Co., Ltd. (TSE:8031).

Yangzijiang Shipbuilding (Holdings) Ltd. (SGX:BS6) acquired additional 5% stake in Jiangsu Yangzi-Mitsui Shipbuilding Co. Ltd. from Mitsui & Co., Ltd. (TSE:8031) and Mitsui E&S Shipbuilding Co., Ltd for CNY 43.2 million.

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Mitsui & Co., Ltd. (TSE:8031) executed a share purchase agreement to acquire STATS (UK) Ltd from BGF Investment Management Ltd. and others.

Mitsui & Co., Ltd. to Report Q1, 2024 Results on Aug 01, 2023

Mitsui & Co., Ltd. (TSE:8031) entered into binding agreements to acquire minority shareholder in EURICOM S.p.a. for enterprise value approximately €500 million.

Mitsui, Osaka Gas Reportedly Bid for ReNew Energy's Commercial and Industrial Project Portfolio

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of JP¥70.00 per share at 3.4% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire remaining 50% stake in Aim Services Co., Ltd. from Aramark (NYSE:ARMK) for ¥70 billion.

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Mitsui & Co., Ltd. Announces Management Changes

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Sumitomo Pharma Animal Health Co., Ltd. from Sumitomo Pharma Co., Ltd. (TSE:4506).

Mitsui & Co., Ltd. to Report Nine Months, 2023 Results on Feb 03, 2023

Price target increased to JP¥4,418

CFW Partners, L.P, Mitsui & Co., Ltd. (TSE:8031), Fuyo General Lease Co., Ltd. (TSE:8424) and JA Mitsui Leasing, Ltd. submitted a non-binding proposal to acquire remaining 2.1% stake in Willis Lease Finance Corporation (NasdaqGM:WLFC) for $29.3 million.

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

ACTIS GP LLP completed the acquisition of 40% share in MT Falcon Holdings Company S.A.P.I. de C.V. from Mitsui & Co., Ltd.

Woodside Reportedly Weighs Up Options for Scarborough

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken